iPSCs in Modeling and Therapy of Osteoarthritis

Osteoarthritis (OA) belongs to chronic degenerative disorders and is often a leading cause of disability in elderly patients. Typically, OA is manifested by articular cartilage erosion, pain, stiffness, and crepitus. Currently, the treatment options are limited, relying mostly on pharmacological the...

Full description

Bibliographic Details
Main Authors: Maria Csobonyeiova, Stefan Polak, Andreas Nicodemou, Radoslav Zamborsky, Lubos Danisovic
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/9/2/186
_version_ 1827589442417721344
author Maria Csobonyeiova
Stefan Polak
Andreas Nicodemou
Radoslav Zamborsky
Lubos Danisovic
author_facet Maria Csobonyeiova
Stefan Polak
Andreas Nicodemou
Radoslav Zamborsky
Lubos Danisovic
author_sort Maria Csobonyeiova
collection DOAJ
description Osteoarthritis (OA) belongs to chronic degenerative disorders and is often a leading cause of disability in elderly patients. Typically, OA is manifested by articular cartilage erosion, pain, stiffness, and crepitus. Currently, the treatment options are limited, relying mostly on pharmacological therapy, which is often related to numerous complications. The proper management of the disease is challenging because of the poor regenerative capacity of articular cartilage. During the last decade, cell-based approaches such as implantation of autologous chondrocytes or mesenchymal stem cells (MSCs) have shown promising results. However, the mentioned techniques face their hurdles (cell harvesting, low proliferation capacity). The invention of induced pluripotent stem cells (iPSCs) has created new opportunities to increase the efficacy of the cartilage healing process. iPSCs may represent an unlimited source of chondrocytes derived from a patient’s somatic cells, circumventing ethical and immunological issues. Aside from the regenerative potential of iPSCs, stem cell-derived cartilage tissue models could be a useful tool for studying the pathological process of OA. In our recent article, we reviewed the progress in chondrocyte differentiation techniques, disease modeling, and the current status of iPSC-based regenerative therapy of OA.
first_indexed 2024-03-09T00:56:45Z
format Article
id doaj.art-98b5598d0d174a188caf5ca33d5d94b8
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-09T00:56:45Z
publishDate 2021-02-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-98b5598d0d174a188caf5ca33d5d94b82023-12-11T16:51:12ZengMDPI AGBiomedicines2227-90592021-02-019218610.3390/biomedicines9020186iPSCs in Modeling and Therapy of OsteoarthritisMaria Csobonyeiova0Stefan Polak1Andreas Nicodemou2Radoslav Zamborsky3Lubos Danisovic4Institute of Histology and Embryology, Faculty of Medicine, Comenius University, Sasinkova 4, 811 08 Bratislava, SlovakiaInstitute of Histology and Embryology, Faculty of Medicine, Comenius University, Sasinkova 4, 811 08 Bratislava, SlovakiaInstitute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University, Sasinkova 4, 811 08 Bratislava, SlovakiaNational Institute of Children’s Diseases, Department of Orthopedics, Faculty of Medicine, Comenius University, Limbova 1, 833 40 Bratislava, SlovakiaInstitute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University, Sasinkova 4, 811 08 Bratislava, SlovakiaOsteoarthritis (OA) belongs to chronic degenerative disorders and is often a leading cause of disability in elderly patients. Typically, OA is manifested by articular cartilage erosion, pain, stiffness, and crepitus. Currently, the treatment options are limited, relying mostly on pharmacological therapy, which is often related to numerous complications. The proper management of the disease is challenging because of the poor regenerative capacity of articular cartilage. During the last decade, cell-based approaches such as implantation of autologous chondrocytes or mesenchymal stem cells (MSCs) have shown promising results. However, the mentioned techniques face their hurdles (cell harvesting, low proliferation capacity). The invention of induced pluripotent stem cells (iPSCs) has created new opportunities to increase the efficacy of the cartilage healing process. iPSCs may represent an unlimited source of chondrocytes derived from a patient’s somatic cells, circumventing ethical and immunological issues. Aside from the regenerative potential of iPSCs, stem cell-derived cartilage tissue models could be a useful tool for studying the pathological process of OA. In our recent article, we reviewed the progress in chondrocyte differentiation techniques, disease modeling, and the current status of iPSC-based regenerative therapy of OA.https://www.mdpi.com/2227-9059/9/2/186osteoarthritisiPSCsarticular cartilagestem cell-based therapydisease modeling
spellingShingle Maria Csobonyeiova
Stefan Polak
Andreas Nicodemou
Radoslav Zamborsky
Lubos Danisovic
iPSCs in Modeling and Therapy of Osteoarthritis
Biomedicines
osteoarthritis
iPSCs
articular cartilage
stem cell-based therapy
disease modeling
title iPSCs in Modeling and Therapy of Osteoarthritis
title_full iPSCs in Modeling and Therapy of Osteoarthritis
title_fullStr iPSCs in Modeling and Therapy of Osteoarthritis
title_full_unstemmed iPSCs in Modeling and Therapy of Osteoarthritis
title_short iPSCs in Modeling and Therapy of Osteoarthritis
title_sort ipscs in modeling and therapy of osteoarthritis
topic osteoarthritis
iPSCs
articular cartilage
stem cell-based therapy
disease modeling
url https://www.mdpi.com/2227-9059/9/2/186
work_keys_str_mv AT mariacsobonyeiova ipscsinmodelingandtherapyofosteoarthritis
AT stefanpolak ipscsinmodelingandtherapyofosteoarthritis
AT andreasnicodemou ipscsinmodelingandtherapyofosteoarthritis
AT radoslavzamborsky ipscsinmodelingandtherapyofosteoarthritis
AT lubosdanisovic ipscsinmodelingandtherapyofosteoarthritis